(19)
(11)
EP 1 377 833 A2
(12)
(88)
Date of publication A3:
30.10.2003
(43)
Date of publication:
07.01.2004
Bulletin 2004/02
(21)
Application number:
02730159.7
(22)
Date of filing:
15.04.2002
(51)
International Patent Classification (IPC)
7
:
G01N
33/576
,
C12Q
1/28
,
C07K
16/00
,
A61P
31/00
,
A61K
39/00
,
C12N
15/00
,
A61K
48/00
,
A61K
39/29
(86)
International application number:
PCT/EP2002/004167
(87)
International publication number:
WO 2002/084294
(
24.10.2002
Gazette 2002/43)
(84)
Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI
(30)
Priority:
13.04.2001
US 283345 P
(71)
Applicant:
Axxima Pharmaceuticals Aktiengesellschaft
82152 Martinsried (DE)
(72)
Inventors:
HERGET, Thomas
82152 Planegg (DE)
COTTEN, Matthew
80799 Munich (DE)
OBERT, Sabine
81475 Munich (DE)
(74)
Representative:
Leidescher, Thomas, Dr. et al
Zimmermann & Partner,Postfach 330 920
80069 München
80069 München (DE)
(54)
GASTROINTESTINAL GLUTATHIONE PEROXIDASE IN HEPATITIS C VIRUS INFECTIONS